Belmontesi, M
Medically reviewed by: Dr Hoe Ying Min, Medical Director, Bay Aesthetics Clinic Last medically reviewed: July 2026 Semaglutide is a GLP-1 receptor agonist medication used to treat type 2 diabetes and, in higher doses, obesity
NOT for clinical, diagnostic, or therapeutic purposes
Just remember: peptides are tools not shortcuts
It seems that weight loss will likely be very important for the benefits of the GLP-1 medicines in some conditions, and much less important, or not at all essential, for benefits in other disorders. According to Lane, although GLP-1 receptor agonists show promise in reducing cardiovascular risk factors, long-term cardiovascular safety trials are needed to assess cardiovascular mortality and events
2 studies scored seven, indicating medium-quality studies with low risk of bias